Hospital readmission rates and risk factors for readmission following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal surface malignancies
- Resource Type
- Article
- Source
- In
The Surgeon October 2018 16(5):278-282 - Subject
- Language
- ISSN
- 1479-666X